SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-21-028217
Filing Date
2021-05-20
Accepted
2021-05-20 17:20:14
Documents
2
Period of Report
2021-05-20
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea141456-8k_relmada.htm 8-K 32722
2 RELMADA THERAPEUTICS, INC. 2021 EQUITY INCENTIVE PLAN ea141456ex10-1_relmada.htm EX-10.1 154388
  Complete submission text file 0001213900-21-028217.txt   188478
Mailing Address 880 3RD AVENUE, 12TH FLOOR NEW YORK NY 10022
Business Address 880 3RD AVENUE, 12TH FLOOR NEW YORK NY 10022 646 876 3459
RELMADA THERAPEUTICS, INC. (Filer) CIK: 0001553643 (see all company filings)

IRS No.: 455401931 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39082 | Film No.: 21945492
SIC: 2834 Pharmaceutical Preparations